Last updated: 31 May 2024 at 4:45pm EST

Antoine Papiernik Net Worth




The estimated Net Worth of Antoine Papiernik is at least $316 Million dollars as of 5 July 2023. Mr. Papiernik owns over 17,381 units of Shockwave Medical stock worth over $7,586,105 and over the last 6 years he sold SWAV stock worth over $308,447,846. In addition, he makes $185,253 as Independent Director at Shockwave Medical.

Mr. Papiernik SWAV stock SEC Form 4 insiders trading

Antoine has made over 32 trades of the Shockwave Medical stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 17,381 units of SWAV stock worth $295,477 on 5 July 2023.

The largest trade he's ever made was selling 650,000 units of Shockwave Medical stock on 4 September 2019 worth over $22,327,500. On average, Antoine trades about 101,233 units every 35 days since 2019. As of 5 July 2023 he still owns at least 22,662 units of Shockwave Medical stock.

You can see the complete history of Mr. Papiernik stock trades at the bottom of the page.





Antoine Papiernik biography

Antoine Papiernik serves as Independent Director of the Company. Mr. Papiernik has been Managing Partner of Sofinnova Partners since 1997. Mr. Papiernik has been an initial investor and a board member in public companies, including ProQr Therapeutics N.V. and Mainstay Medical International plc. Mr. Papiernik is also a board member of private companies MedDay Pharmaceuticals, MD Start, Reflexion Medical, Gecko Biomedical, SafeHeal, Highlife and Rgenix. Mr. Papiernik served on the boards of EOS (Ethical Oncology Science S.p.A., CoAxia, Lectus Therapeutics Ltd, Entourage Medical Technologies, Inc., Corwave SA, Auris Medical Holding and Impatients. Mr. Papiernik previously was an initial investor and a board member of the following companies, Actelion Pharmaceuticals Ltd. (“Actelion”), NovusPharma S.p.A. (sold to Cell Therapeutics, Inc.), Movetis NV (sold to Shire Plc), Pixium Vision SA and Stentys S, which went public respectively on the Zürich stock exchange, Nasdaq, the Stockholm stock exchange, the Milan Nuovo Mercato, the Belgium Stock Exchange and the EuroNext Paris. He was also a board member for Cotherix Inc. (initially Nasdaq listed, then sold to Actelion), CoreValve (sold to Medtronic plc), Fovea Pharmaceuticals (sold to Sanofi-Aventis S.A.) and ReCor Medical, Inc. (sold to Otsuka Pharmaceutical Co., Ltd.). Mr. Papiernik received his M.B.A. from the Wharton School of Business, University of Pennsylvania and his B.S. from Institut Etudes Economiques Commerciales.

What is the salary of Antoine Papiernik?

As the Independent Director of Shockwave Medical, the total compensation of Antoine Papiernik at Shockwave Medical is $185,253. There are 8 executives at Shockwave Medical getting paid more, with Douglas Godshall having the highest compensation of $2,208,320.



How old is Antoine Papiernik?

Antoine Papiernik is 53, he's been the Independent Director of Shockwave Medical since 2019. There are 10 older and 4 younger executives at Shockwave Medical. The oldest executive at Shockwave Medical Inc. is John M. Adams, 74, who is the Co-Founder and Technical Advisor.

What's Antoine Papiernik's mailing address?

Antoine's mailing address filed with the SEC is C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA, CA, 95054.

Insiders trading at Shockwave Medical

Over the last 6 years, insiders at Shockwave Medical have traded over $488,603,927 worth of Shockwave Medical stock and bought 30,000 units worth $510,000 . The most active insiders traders include James E Deerfield Mgmt L.P...., Antoine Papiernik, and Capital Vii Fcpr Sofinnova. On average, Shockwave Medical executives and independent directors trade stock every 8 days with the average trade being worth of $10,693,924. The most recent stock trade was executed by Trinh Phung on 17 May 2024, trading 19,763 units of SWAV stock currently worth $121,740.



What does Shockwave Medical do?

shockwave medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. inspired by 30-years of safety and efficacy in kidney stone treatment, our lithoplasty® family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. lithoplasty devices use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. an integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. in peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, lithoplasty technology demonstrated safety and consistent procedure success with low procedural complications. the technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatmen



What does Shockwave Medical's logo look like?

Shockwave Medical Inc. logo

Complete history of Mr. Papiernik stock trades at Shockwave Medical

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
5 Jul 2023 Antoine Papiernik
Director
Option 17,381 $17.00 $295,477
5 Jul 2023
22,662
12 Aug 2022 Antoine Papiernik
Director
Sale 50,000 $288.11 $14,405,500
12 Aug 2022
12,251
10 Mar 2022 Antoine Papiernik
Director
Sale 60,000 $163.38 $9,802,800
10 Mar 2022
62,251
26 May 2021 Antoine Papiernik
Director
Sale 110,000 $171.35 $18,848,500
26 May 2021
122,251
1 Mar 2021 Antoine Papiernik
Director
Sale 555,000 $120.00 $66,600,000
1 Mar 2021
232,251
22 Feb 2021 Antoine Papiernik
Director
Sale 350,000 $127.50 $44,625,000
22 Feb 2021
787,251
20 Nov 2020 Antoine Papiernik
Director
Sale 68,855 $98.87 $6,807,694
20 Nov 2020
1,137,251
17 Nov 2020 Antoine Papiernik
Director
Sale 11,710 $96.39 $1,128,727
17 Nov 2020
1,206,106
13 Nov 2020 Antoine Papiernik
Director
Sale 68,514 $93.79 $6,425,928
13 Nov 2020
1,217,816
11 Nov 2020 Antoine Papiernik
Director
Sale 75,276 $88.81 $6,685,262
11 Nov 2020
1,286,330
9 Nov 2020 Antoine Papiernik
Director
Sale 104,400 $82.69 $8,632,836
9 Nov 2020
1,361,606
16 Oct 2020 Antoine Papiernik
Director
Sale 16,619 $79.13 $1,315,061
16 Oct 2020
1,466,006
9 Oct 2020 Antoine Papiernik
Director
Sale 1,581 $79.00 $124,899
9 Oct 2020
1,482,625
5 Oct 2020 Antoine Papiernik
Director
Sale 29,000 $77.13 $2,236,770
5 Oct 2020
1,484,206
30 Sep 2020 Antoine Papiernik
Director
Sale 17,744 $75.32 $1,336,478
30 Sep 2020
1,513,206
28 Sep 2020 Antoine Papiernik
Director
Sale 30,603 $73.95 $2,263,092
28 Sep 2020
1,530,950
18 Sep 2020 Antoine Papiernik
Director
Sale 12,653 $73.19 $926,073
18 Sep 2020
1,561,553
14 Sep 2020 Antoine Papiernik
Director
Sale 120,000 $69.06 $8,287,200
14 Sep 2020
1,574,206
25 Aug 2020 Antoine Papiernik
Director
Sale 84,202 $60.04 $5,055,488
25 Aug 2020
1,854,646
24 Aug 2020 Antoine Papiernik
Director
Sale 160,440 $60.43 $9,695,389
24 Aug 2020
1,694,206
20 Aug 2020 Antoine Papiernik
Director
Sale 55,358 $60.01 $3,322,034
20 Aug 2020
1,938,848
17 Aug 2020 Antoine Papiernik
Director
Sale 285,623 $55.55 $15,866,358
17 Aug 2020
1,994,206
12 Aug 2020 Antoine Papiernik
Director
Sale 14,377 $55.01 $790,879
12 Aug 2020
2,555,265
6 Aug 2020 Antoine Papiernik
Director
Sale 71,722 $50.93 $3,652,801
6 Aug 2020
2,534,096
3 Aug 2020 Antoine Papiernik
Director
Sale 228,278 $50.35 $11,493,797
3 Aug 2020
2,605,818
9 Jun 2020 Antoine Papiernik
Director
Sale 171,071 $46.89 $8,021,519
9 Jun 2020
2,834,096
4 Jun 2020 Antoine Papiernik
Director
Sale 119,633 $45.07 $5,391,859
4 Jun 2020
3,005,167
1 Jun 2020 Antoine Papiernik
Director
Sale 9,296 $45.02 $418,506
1 Jun 2020
3,124,800
22 Jan 2020 Antoine Papiernik
Director
Sale 54,920 $43.93 $2,412,636
22 Jan 2020
3,134,096
16 Jan 2020 Antoine Papiernik
Director
Sale 328,000 $44.20 $14,497,600
16 Jan 2020
2,922,475
14 Jan 2020 Antoine Papiernik
Director
Sale 117,080 $43.13 $5,049,660
14 Jan 2020
3,250,475
4 Sep 2019 Antoine Papiernik
Director
Sale 650,000 $34.35 $22,327,500
4 Sep 2019
3,394,206


Shockwave Medical executives and stock owners

Shockwave Medical executives and other stock owners filed with the SEC include: